vs
NEXPOINT DIVERSIFIED REAL ESTATE TRUST（NXDT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是NEXPOINT DIVERSIFIED REAL ESTATE TRUST的1.9倍（$35.5M vs $18.4M），NEXPOINT DIVERSIFIED REAL ESTATE TRUST净利率更高（-193.1% vs -304.2%，领先111.1%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -29.0%），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 19.9%）
NexPoint多元化房地产信托是一家美国上市房地产投资信托，专注于收购、运营和优化覆盖多户住宅、工业物业、办公楼及社区零售空间的多元资产组合，通过租金收入和长期资产增值为投资者创造回报。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
NXDT vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.4M | $35.5M |
| 净利润 | $-35.5M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | -18.8% | -304.8% |
| 净利率 | -193.1% | -304.2% |
| 营收同比 | -29.0% | 681.7% |
| 净利润同比 | -291.1% | 39.6% |
| 每股收益（稀释后） | $-0.73 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $18.4M | $35.5M | ||
| Q3 25 | $17.5M | $5.2M | ||
| Q2 25 | $21.0M | $19.2M | ||
| Q1 25 | $29.1M | $14.7M | ||
| Q4 24 | $25.9M | $4.5M | ||
| Q3 24 | $22.2M | $26.1M | ||
| Q2 24 | $22.3M | $14.4M | ||
| Q1 24 | $12.8M | $13.8M |
| Q4 25 | $-35.5M | $-108.1M | ||
| Q3 25 | $-13.7M | $-162.3M | ||
| Q2 25 | $-45.3M | $-171.9M | ||
| Q1 25 | $-34.3M | $-202.5M | ||
| Q4 24 | $-9.1M | $-178.9M | ||
| Q3 24 | $-10.0M | $-95.8M | ||
| Q2 24 | $-9.8M | $-97.5M | ||
| Q1 24 | $-22.7M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | -18.8% | -304.8% | ||
| Q3 25 | -19.1% | -3327.6% | ||
| Q2 25 | -0.6% | -916.8% | ||
| Q1 25 | 19.0% | -1297.9% | ||
| Q4 24 | 3.6% | -4042.4% | ||
| Q3 24 | -26.8% | -377.1% | ||
| Q2 24 | 2.7% | -697.4% | ||
| Q1 24 | 2.1% | -698.4% |
| Q4 25 | -193.1% | -304.2% | ||
| Q3 25 | -78.4% | -3135.3% | ||
| Q2 25 | -215.1% | -894.2% | ||
| Q1 25 | -118.0% | -1373.3% | ||
| Q4 24 | -35.0% | -3935.5% | ||
| Q3 24 | -45.2% | -367.5% | ||
| Q2 24 | -43.9% | -676.6% | ||
| Q1 24 | -177.3% | -662.4% |
| Q4 25 | $-0.73 | $-0.17 | ||
| Q3 25 | $-0.29 | $-0.36 | ||
| Q2 25 | $-0.99 | $-0.41 | ||
| Q1 25 | $-0.80 | $-0.50 | ||
| Q4 24 | $-0.20 | $-0.56 | ||
| Q3 24 | $-0.25 | $-0.34 | ||
| Q2 24 | $-0.24 | $-0.40 | ||
| Q1 24 | $-0.59 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.2M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $700.1M | $1.1B |
| 总资产 | $1.1B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $8.2M | $743.3M | ||
| Q3 25 | $5.3M | $659.8M | ||
| Q2 25 | $4.7M | $525.1M | ||
| Q1 25 | $9.5M | $500.5M | ||
| Q4 24 | $8.8M | $594.4M | ||
| Q3 24 | $8.5M | $427.6M | ||
| Q2 24 | $28.4M | $474.3M | ||
| Q1 24 | $20.2M | $296.3M |
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $700.1M | $1.1B | ||
| Q3 25 | $739.0M | $1.0B | ||
| Q2 25 | $752.7M | $919.1M | ||
| Q1 25 | $802.7M | $933.9M | ||
| Q4 24 | $836.5M | $1.0B | ||
| Q3 24 | $842.9M | $524.6M | ||
| Q2 24 | $859.1M | $584.4M | ||
| Q1 24 | $863.0M | $401.2M |
| Q4 25 | $1.1B | $1.5B | ||
| Q3 25 | $1.1B | $1.4B | ||
| Q2 25 | $1.1B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.2B | $1.4B | ||
| Q3 24 | $1.2B | $726.5M | ||
| Q2 24 | $1.2B | $775.9M | ||
| Q1 24 | $1.1B | $557.8M |
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.2M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | — | $-47.3M |
| 自由现金流率自由现金流/营收 | — | -133.1% |
| 资本支出强度资本支出/营收 | — | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $9.2M | $-46.1M | ||
| Q3 25 | $835.0K | $-117.4M | ||
| Q2 25 | $75.0K | $-76.4M | ||
| Q1 25 | $7.1M | $-132.0M | ||
| Q4 24 | $-11.7M | $-115.4M | ||
| Q3 24 | $497.0K | $-59.2M | ||
| Q2 24 | $-5.5M | $-82.2M | ||
| Q1 24 | $-2.6M | $-102.3M |
| Q4 25 | — | $-47.3M | ||
| Q3 25 | — | $-117.6M | ||
| Q2 25 | — | $-79.6M | ||
| Q1 25 | — | $-133.8M | ||
| Q4 24 | — | $-116.7M | ||
| Q3 24 | — | $-63.8M | ||
| Q2 24 | — | $-83.4M | ||
| Q1 24 | — | $-109.0M |
| Q4 25 | — | -133.1% | ||
| Q3 25 | — | -2272.5% | ||
| Q2 25 | — | -413.9% | ||
| Q1 25 | — | -907.4% | ||
| Q4 24 | — | -2567.7% | ||
| Q3 24 | — | -244.6% | ||
| Q2 24 | — | -578.5% | ||
| Q1 24 | — | -789.9% |
| Q4 25 | — | 3.5% | ||
| Q3 25 | — | 4.7% | ||
| Q2 25 | — | 16.4% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | 28.6% | ||
| Q3 24 | — | 17.5% | ||
| Q2 24 | — | 8.2% | ||
| Q1 24 | — | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
